These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22713463)
1. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Xu N; Zhang J; Shen C; Luo Y; Xia L; Xue F; Xia Q Biochem Biophys Res Commun; 2012 Jul; 423(4):826-31. PubMed ID: 22713463 [TBL] [Abstract][Full Text] [Related]
2. Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Xu N; Shen C; Luo Y; Xia L; Xue F; Xia Q; Zhang J Biochem Biophys Res Commun; 2012 Aug; 425(2):468-72. PubMed ID: 22846564 [TBL] [Abstract][Full Text] [Related]
3. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Qin J; Luo M; Qian H; Chen W Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717 [TBL] [Abstract][Full Text] [Related]
4. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824 [TBL] [Abstract][Full Text] [Related]
5. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer. Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020 [TBL] [Abstract][Full Text] [Related]
6. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1. Ou Y; Zhai D; Wu N; Li X Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754 [TBL] [Abstract][Full Text] [Related]
9. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
10. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. Huang N; Lin J; Ruan J; Su N; Qing R; Liu F; He B; Lv C; Zheng D; Luo R FEBS Lett; 2012 Mar; 586(6):884-91. PubMed ID: 22449976 [TBL] [Abstract][Full Text] [Related]
11. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells. Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983 [TBL] [Abstract][Full Text] [Related]
12. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
13. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy. Yin W; Nie Y; Zhang Z; Xie L; He X Oncol Rep; 2015 Jul; 34(1):368-74. PubMed ID: 25997995 [TBL] [Abstract][Full Text] [Related]
14. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma. Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144 [TBL] [Abstract][Full Text] [Related]
15. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Shen Q; Cicinnati VR; Zhang X; Iacob S; Weber F; Sotiropoulos GC; Radtke A; Lu M; Paul A; Gerken G; Beckebaum S Mol Cancer; 2010 Aug; 9():227. PubMed ID: 20799954 [TBL] [Abstract][Full Text] [Related]
16. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Xu Y; An Y; Wang Y; Zhang C; Zhang H; Huang C; Jiang H; Wang X; Li X Oncol Rep; 2013 May; 29(5):2019-24. PubMed ID: 23483142 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance. Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-199a-5p inhibits VEGF-induced tumorigenesis through targeting oxidored-nitro domain-containing protein 1 in human HepG2 cells. Gui R; Huang R; Zhang JH; Wen XH; Nie XM Oncol Rep; 2016 Apr; 35(4):2216-22. PubMed ID: 26781989 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970 [TBL] [Abstract][Full Text] [Related]
20. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG. Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]